Navigation Links
Enhancing Survival Rate Of Lung Cancer Patients

Investigators in an international study found the survival rate of non-small-cell lung cancer patients after its removal // improved with cisplatin-based adjuvant chemotherapy. Cisplatin is an anti-neoplastic medication that interferes with the growth of cancer cells and slows their growth and spread in the body.

Researchers randomly assigned 1,867 patients to receive either three or four cycles of cisplatin-based chemotherapy or observation. In addition to cisplatin, the drug etoposide was given to about 56 percent of patients; the drug vinorelbine was given to about 26 percent of patients; vinblastine was given to 11 percent of patients, and vindesine was given to nearly 6 percent of patients. Of the 932 patients assigned to chemotherapy, nearly 73 percent received at least 240 milligrams of cisplatin per square meter of body-surface area.

Results of the study showed that after five years, patients assigned to chemotherapy had a significantly higher survival rate at 44.5 percent than those assigned to observation who had a 40.4 survival rate at five years. Patients assigned to chemotherapy also had a significantly higher disease-free survival rate at 39.4 percent than those assigned to observation with 34.3 percent.

Thus researchers say their results indicate that roughly 7,000 deaths from non-small-cell carcinoma would be averted annually with the use of adjuvant cisplatin-based chemotherapy.
'"/>




Page: 1

Related medicine news :

1. Enhancing Infants Immune System
2. Rescuing Injured Hearts by Enhancing Regeneration
3. Saudi Arabia for Enhancing Health Sector Ties with India
4. Elevate End- Of- Life Experience by Enhancing Quality of Hospice Care
5. Testosterone Cream – Ineffective in Enhancing Libido in Female Cancer Survivor
6. Long-Term Survival can be Predicted by a Simple Lung Test
7. Hepatitis G May Boost HIV Survival
8. Survival rates in breast cancer patients improved with "Dose Dense Chemotherapy"
9. Longer Lung Cancer Survival
10. ICU Survival can be improved by Antibiotic use
11. Vasopressin Found To Boost Survival In Sudden Cardiac arrest
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/21/2017)... ... ... Seamild, the largest manufacturer of oats in China, is now aiming at global ... is recognized globally as one of the healthiest cereals, XieQingkui, the founder of Seamild, ... move to sow the seed of good karma. Buddhism spirit featuring benevolence and sacrifice ...
(Date:1/21/2017)... Pekin, IL (PRWEB) , ... January 21, 2017 , ... ... disorders. Even when individuals experience the freedom of recovery, they often feel shame for ... abuse and post-traumatic stress disorder (PTSD). In the workshop, “Rising Strong in Life After ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and ... essential oils, announced the company had a successful visit to the 2017 ECRM Diet, ... gives companies that work in the nutritional, sports and health industries a chance to ...
(Date:1/20/2017)... ... January 20, 2017 , ... International Protein, a company based out ... announced it attended the January ECRM trade show in Hilton Head, SC. , ... was determined to create a line of products that would elevate her fitness regime. ...
(Date:1/20/2017)... ... ... “The Angel”: a heartwarming and earnest tale of faith and believing in the ... is the creation of published author, Marjorie Lund-Fontaine, a former professional violinist, alumnus of ... asked of her new book, Marjorie says, “‘The Angel’ was written as a fairytale, ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 Conference Call and Webcast to ... ) today announced it will release results for the fourth quarter ... ... host a conference call at 4:30 PM ET on Wednesday, February ... full year 2016 financial results and other corporate activities. To participate ...
(Date:1/19/2017)... , Jan. 19, 2017 This report ... current and future scenario of the global market. Large ... opioid consumption. Severe chronic constipation is a major side ... traditional laxatives. Hence, novel targeted therapy has been prescribed ... sufferers, launch of targeted medicines, and growing awareness about ...
(Date:1/19/2017)...  Stealth BioTherapeutics Inc. ( Stealth ), a clinical-stage ... announced new additions to its senior leadership team: ... and Daniel Geffken as interim Chief Financial ... , Pharm.D. has been promoted to Chief Clinical Development ... Doug and Daniel to our management team, as both ...
Breaking Medicine Technology: